ベンズニダゾール

危険有害性情報のコード(GHS)

• 絵表示(GHS)

  

• 注意喚起語

  Warning

• 危険有害性情報

  H315：皮膚刺激

  H319：強い眼刺激

  H335：呼吸器への刺激のおそれ

• 注意書き

  P261：粉じん/煙/ガス/ミスト/蒸気/スプレーの吸入を避ける こと。

  P264：取扱い後は皮膚をよく洗うこと。

  P264：取扱い後は手や顔をよく洗うこと。

  P271：屋外または換気の良い場所でのみ使用すること。

  P280：保護手袋/保護衣/保護眼鏡/保護面を着用するこ と。

  P302+P352：皮膚に付着した場合：多量の水と石鹸で洗うこと。

  P305+P351+P338：眼に入った場合：水で数分間注意深く洗うこと。次にコ ンタクトレンズを着用していて容易に外せる場合は外す こと。その後も洗浄を続けること。

ベンズニダゾール 価格

ベンズニダゾール 化学特性,用途語,生産方法

• 効能

  抗原虫薬

• 説明

  Benznidazole is the second of the drugs approved for treatment of Chagas' disease. Like nifurtimox, it is effective against the circulating form of Trypanosoma cruzi during the acute phase of the disease, but also like nifurtimox, it is ineffective during the chronic stage of the disease.

• 使用

  Benznidazole (BNZ) is traditionally used to treat Chagas disease caused by Trypanosoma cruzi. The drugs used for the treatment of this disease, Nifurtimox and Benznidazole, are toxic and present sever e side effects.

• 定義

  ChEBI: A monocarboxylic acid amide obtained by formal condensation of the carboxy group of (2-nitroimidazol-1-yl)acetic acid with the aromatic amino group of benzylamine. Used for treatment of Chagas disease.

• 抗菌性

  It exhibits antiprotozoal activity, particularly against Trypanosoma cruzi.

• 一般的な説明

  N-Benzyl-2-nitro-1H-imidazole-1-acetamide (Benznidazole) is a nitro-heterocyclic compound. It is widely employed drug for the treatment of Chagas disease. It exhibits three polymorphic forms..

• 応用例（製薬）

  A synthetic 2-nitroimidazole, formulated for oral administration. Solubility in water 400 mg/L.

• 作用機序

  Studies suggest that benznidazole does not catalyze the formation of ROS and, therefore, has a mechanism of action different from that of nifurtimox. It has been proposed that benznidazole undergoes an one-electron transfer to the nitro group, which in turn dismutates to give back the nitroimidazole and a nitrosoimidazole. The latter product may then undergo an electrophilic addition to trypanothione, which leads to depletion of trypanothione, an essential enzyme system in the Trypanosoma cruzi.

• 薬物動態学

  Oral bioavailability :High
  Cmax 100 mg oral ：2.2–2.8 mg/L after 3–4 h
  Plasma half-life：10.5–13.6 h
  Volume of distribution：c. 0.56 L/kg
  Plasma protein binding： c. 44%
  The 2-nitro group undergoes reduction to the amine and hydrolysis to the hydroxy derivative.

• 臨床応用

  Benznidazole is used in treatment of South American trypanosomiasis (Chagas disease).

• 副作用

  Adverse effects are more common in the elderly and include nausea, vomiting, abdominal pain, peripheral neuropathy and severe skin reactions.

ベンズニダゾール 生産企業

Global(96)Suppliers

ベンズニダゾール スペクトルデータ(IR)

22994-85-0, ベンズニダゾール キーワード